Percutaneous Dilatational Tracheostomy vs. Surgical Tracheostomy in Neurocritically Ill Patients - a Retrospective Study
Launched by RIGSHOSPITALET, DENMARK · Aug 28, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of performing a tracheostomy—a procedure where a hole is made in the neck to help a person breathe—specifically in patients who are critically ill and being treated in a neurointensive care unit. The goal is to find out if one method leads to fewer complications than the other and to understand how factors like the skill level of the healthcare provider and the timing of the procedure affect patient outcomes.
To be eligible for this study, patients must be 18 years or older and have had a tracheostomy during their stay at Rigshospitalet in Denmark. Participants can expect to have their health outcomes monitored after the procedure, and the study will look at various factors like how long they stay in the hospital and how quickly they can stop using the tracheostomy. This research aims to improve the care of critically ill patients by better understanding the best practices for performing tracheostomies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients admitted to Neurointensive Care Unit, Rigshospitalet, Denmark AND having a tracheostomy performed during their stay.
- • -
- Exclusion Criteria:
- • Children - age \< 18.
About Rigshospitalet, Denmark
Rigshospitalet, located in Copenhagen, Denmark, is one of the leading hospitals in Scandinavia and a prominent center for clinical research and innovation. As a key academic institution affiliated with the University of Copenhagen, Rigshospitalet is dedicated to advancing healthcare through rigorous clinical trials and groundbreaking research across various medical disciplines. The hospital’s commitment to excellence is reflected in its multidisciplinary approach, collaboration with international research networks, and focus on improving patient outcomes through evidence-based practices. With state-of-the-art facilities and a team of highly qualified professionals, Rigshospitalet plays a crucial role in translating scientific discoveries into effective treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Patients applied
Trial Officials
Martin K Soerensen, PHD
Study Chair
Department of Neruoanaesthesiology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported